Russell Investments Group’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Russell Investments Group’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-62,131	Closed	-$174K	–	3210
2019 Q4	$174K	Buy	+62,131	New	+$199K	﹤0.01%	2750
2019 Q1	–	Sell	-590	Closed	-$14K	–	3073
2018 Q4	$14K	Hold	590	–	–	﹤0.01%	2882
2018 Q3	$33K	Sell	590 -30	-5%	-$1.92K	﹤0.01%	2880
2018 Q2	$44K	Sell	620 -55	-8%	-$3.88K	﹤0.01%	2822
2018 Q1	$41K	Hold	675	–	–	﹤0.01%	2842
2017 Q4	$87K	Sell	675 -25	-4%	-$3.2K	﹤0.01%	2802
2017 Q3	$96K	Sell	700 -20	-3%	-$2.67K	﹤0.01%	2780
2017 Q2	$103K	Sell	720 -2,478	-77%	-$383K	﹤0.01%	2801
2017 Q1	$588K	Buy	3,198 +1,340	+72%	+$150K	﹤0.01%	2364
2016 Q4	$156K	Buy	+1,858	New	+$147K	﹤0.01%	2769

Other funds holding TTPH

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Russell Investments Group's TTPH Position: Q1 2020 in Review

Russell Investments Group sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q1 2020, closing a stake of 62,131 shares — an estimated $174K sold.

Russell Investments Group first reported a position in TTPH in Q4 2016 and held it in 10 quarters. The position peaked at $588K in Q1 2017. 25 funds tracked by Wall St. Rank hold TTPH as of Q1 2020.

Russell Investments Group reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Russell Investments Group sold 62,131 Tetraphase Pharmaceuticals, Inc. shares in Q1 2020, an estimated $174K.
Russell Investments Group first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2016 and held it in 10 quarters.
Russell Investments Group's Tetraphase Pharmaceuticals, Inc. position peaked at $588K in Q1 2017.
25 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2020.

Based on Russell Investments Group's 13F filing for Q1 2020, filed 6 May 2020.